Felix Ampomah; Analyst; Stephens, Inc. Good morning ladies and gentlemen, and welcome to Fennec Pharmaceuticals fourth quarter and full year 2024 earnings and corporate update conference call.

Fennec Pharmaceuticals shares were down after the company reported fourth-quarter results. The stock was recently down 10% to $6.20 and is down about 2% this year. Revenue declined to $7.93 ...

FENNEC PHARMACEUTICALS ($FENC) posted quarterly earnings results on Monday, March 10th. The company reported earnings of -$0.06 per share, missing estimates of $0.17 ...

(RTTNews) - Fennec Pharmaceuticals Inc (FENC) released Loss for fourth quarter that decreased from last year and beat the Street estimates. The company's earnings totaled -$1.62 million ...

Fennec Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.06 EPS, expectations were $0.56. Operator: Good morning, ladies and gentlemen, and welcome to Fennec ...

Early Repayment of $13 Million of the Company’s Approximately $32 Million Outstanding Convertible Debt Facility: In December 2024, Fennec announced the early partial repayment of a significant ...

Early Repayment of $13 Million of the Company’s Approximately $32 Million Outstanding Convertible Debt Facility: In December 2024, Fennec announced the early partial repayment of a significant portion ...

After hours: March 11 at 4:05:05 PM EDT Loading Chart for FENC ...